Molecular Partners AG (SWX:MOLN)
3.360
+0.020 (0.60%)
Apr 29, 2026, 5:30 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 125.70 million as of April 29, 2026. Its market cap has increased by 12.14% in one year.
Market Cap
125.70M
Enterprise Value
36.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.36
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 125.70M, a decrease of -70.50%. That is a compound annual growth rate of -10.08%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xlife Sciences AG | 122.85M |
| BioVersys AG | 167.25M |
| Santhera Pharmaceuticals Holding AG | 255.69M |
| Newron Pharmaceuticals | 318.74M |
| MindMaze Therapeutics Holding | 45.93M |
| Basilea Pharmaceutica AG | 653.91M |
| Idorsia | 946.67M |
| EvoNext Holdings | 7.07M |